Condition: Rhinitis Acute · Rhinitis Viral · Rhinosinusitis Acute · Sponsor: University Hospital, Clermont-Ferrand
The objective of this study is to conduct post-marketing clinical follow-up of four products: NS, NHE, NHG, and PIR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of acute viral rhinitis, rhinosinusitis, and rhinopharyngitis, while also assessing the benefit/risk ratio of the products.
This description comes directly from the study's public registry record.
Lise Laclautre · +33473754963 · promo_interne_drci@chu-clermontferrand.fr
Lise Laclautre
Always discuss trial participation with your own doctor first.
| Plateforme d'investigation clinique/Centre d'Investigation Clinique, Inserm CIC 1405 | Clermont-Ferrand, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07383493